March 8, 2017 / 9:28 PM / 8 months ago

BRIEF-Oncomed Pharmaceuticals Q4 loss per share $0.60

March 8 (Reuters) - Oncomed Pharmaceuticals Inc:

* Oncomed Pharmaceuticals announces fourth quarter and full year 2016 financial results

* Q4 loss per share $0.60

* Q4 revenue $6.2 million versus $6.8 million

* Oncomed Pharmaceuticals Inc - Oncomed expects operating cash burn to be less than $100 million for full year 2017

* Oncomed Pharmaceuticals Inc - current cash is estimated to be sufficient to fund operations through Q3 of 2018

* Q4 earnings per share view $-0.68 -- Thomson Reuters I/B/E/S

* Q4 revenue view $8.9 million -- Thomson Reuters I/B/E/S Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below